Comparative evaluation of the effects of labetalol, verapamil and diltiazem on antipyrine and indocyanine green clearances.
The effects of labetalol, diltiazem and verapamil on antipyrine and indocyanine green clearance were evaluated in a placebo-controlled, repeated measures evaluation. Twelve healthy subjects received either labetalol (200 mg every 12 hours), diltiazem (90 mg. every 8 hours), verapamil (80 mg every 8 hours), or placebo (every 12 hours) for 4 days. On the morning of Day 3 immediately following their dose, the subjects assumed the supine position for 90 minutes, after which time a 0.5 mg/kg dose of indocyanine green was administered. Blood samples were obtained serially over a 20 minutes period for indocyanine green plasma concentration determinations by HPLC. Ten minutes later, subjects ingested a 1.2 Gm. dose of antipyrine and blood samples were obtained over a 48 hour period for antipyrine plasma concentration determinations by HPLC. A 2 week washout period separated treatment sequences. Mean (SD) antipyrine clearance (L/hr/kg) following diltiazem [0.028 (0.010)] and verapamil [0.030 (0.012)] treatment was significantly lower than that observed following placebo [0.039 (0.012)]. Antipyrine clearance following labetalol administration [0.033 (0.010)] was not significantly different from that observed following placebo, diltiazem or verapamil administration. No effects of these drugs on indocyanine green clearance could be detected.
Rocci
M L
ML
Division of Clinical Pharmacology, Jefferson Medical College, Philadelphia, PA.
Vlasses
P H
PH
Lener
M E
ME
Fruncillo
R A
RA
Sirgo
M A
MA
D000328:Adult; D000983:Antipyrine / Q000378:metabolism*; D004110:Diltiazem / Q000494:pharmacology*; D006207:Half-Life; D006801:Humans; D007208:Indocyanine Green / Q000378:metabolism*; D007741:Labetalol / Q000494:pharmacology*; D008297:Male; D011897:Random Allocation; D014700:Verapamil / Q000494:pharmacology*
D014700:Verapamil; D004110:Diltiazem; D007208:Indocyanine Green; D007741:Labetalol; D000983:Antipyrine